Article
Bacteriophage lambda: The path from biology to theranostic agent
13 Mar 2018
Abstract excerpt
Viral particles provide an attractive platform for the engineering of semisynthetic therapeutic nanoparticles. They can be modified both genetically and chemically in a defined manner to alter their surface characteristics, for targeting specific cell types, to improve their pharmacokinetic features and to attenuate (or enhance) their antigenicity. These advantages derive from a detailed understanding of virus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
